Life Summary
Ryu Jei Man is the CEO of Shin Poong Pharmaceutical.

He is focusing on the clinical development and commercialization of new drug pipelines while accelerating the expansion of production capacity.

He was born on November 25, 1956.

He graduated from Kyungbok High School in Seoul and earned a degree in pharmacy from Seoul National University. He also received both his master’s and doctoral degrees in pharmacy from the graduate school of Seoul National University.

He joined the Central Research Institute of Dongwha Pharm as a researcher and worked there for about 28 years, rising to the position of head of the institute (executive vice president). He later moved to Jeil Pharmaceutical as head of the R&D division and then joined Shin Poong Pharmaceutical, where he was appointed CEO in 2014.

He is a new drug development expert who has built extensive experience over a long period in mid-sized pharmaceutical companies such as Dongwha Pharm, Jeil Pharmaceutical, and Shin Poong Pharmaceutical.

He is also a long-serving CEO, marking his 13th year in office at Shin Poong Pharmaceutical.

#ShinPoongPharmaceutical #RyuJeiMan #pharmaceuticalindustry #drugdevelopment #biopharma #clinicaltrials #R&D #CEOprofile #Koreanpharma #healthcareinnovation